Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis

NCT00542984 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: teriparatide 20 micrograms/day subcutaneous
DRUG: salmon calcitonin 100 IU/day subcutaneous

Sponsor

Eli Lilly and Company